Human CD74-PE Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-Human CD74-PE antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | Human CD74-PE |
| Clone | polyclonal |
| Host Species | Mouse |
| Reactive Species | n/a |
| Isotype | n/a |
| Format | unconjugated |
| Size | 100 tests |
| Concentration | n/a |
| Applications | Flow Cytometry (FC/FACS), Immunohistochemistry (IHC) Formalin/ Paraffin, Immunocytochemistry (ICC), Immunoprecipitation (IP), Immunoblot (IB), Blocking (BL) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Specificity: Human CD74. CD74 represents a type II integral membrane protein known as MHC class II-associated invariant chain. It is moderately expressed on B cells and weakly on monocytes and macrophages. CD74 is also found on a subset of activated T cells, Langerhans cells, dendritic cells, and some epithelial cells. CD74 may play a role in antigen processing and presentation through intracellular transport and expression of class II molecules on the cell surface. |
| Immunogen | Immunogen: Cell line SU-DHL-4 nuclei. Buffer Formulation: Supplied in PBS/NaN3 and a stabilizing agent |
| Other Names | [Invariant chain; Ii; class II-specific chaperone], [CD74] |
| Gene, Accession # | [CD74], Gene ID: 396660, NCBI: NP_998939.1 |
| Catalog # | MBS670612 |
| Price | $285 |
| Order / More Info | Human CD74-PE Antibody from MYBIOSOURCE INC. |
| Product Specific References | 1. Epstein AL, Marder RJ, Winter JN, Fox RI. Two new monoclonal antibodies (LN-1, LN-2) reactive in B5 formalin-fixed, paraffin-embedded tissues with follicular center and mantle zone human B lymphocytes and derived tumors. J Immunol. 1984;133:1028-36. (Immunogen, IHC-FS, IHC-PS, ICC, IP)2. Pack M, Trumpfheller C, Thomas D, Park CG, Granelli-Piperno A, Munz C, et al. DEC-205/CD205 dendritic cells are abundant in the white pulp of the human spleen, including the border region between the red and white pulp. Immunology. 2007;123:438-46. (IHC-FS)3. Sarker AB, Akagi T, Jeon HJ, Miyake K, Murakami I, Yoshino T, et al. Bauhinia purpurea--a new paraffin section marker for Reed-Sternberg cells of Hodgkin's disease. A comparison with Leu-M1 (CD15), LN2 (CD74), peanut agglutinin, and Ber-H2 (CD30). Am J Pathol. 1992;141:19-23. (IHC-PS)4. Burton JD, Ely S, Reddy PK, Stein R, Gold DV, Cardillo TM, et al. CD74 is expressed by multiple myeloma and is a promising target for therapy. Clin Cancer Res. 2004;10:6606-11. (IHC-PS, FC)5. Sepp N, Radaszkiewicz T, Meijer CJ, Smolle J, Seewann H, Fritsch P, et al. Specific skin manifestations in acute leukemia with monocytic differentiation. A morphologic and immunohistochemical study of 11 cases. Cancer. 1993;71:124-32. (IHC-PS)6. Triantafilou K, Triantafilou M, Wilson KM, Cherry RJ, Fernandez N. Intracellular and cell surface heterotypic associations of human leukocyte antigen-DR and human invariant chain. Hum Immunol. 1999;60:1101-12. (ICC, IP, FC)7. Imam A, Taylor CR, inventors; University of Southern California, assignee. Antigen specifically expressed on the surface of B cells and Hodgkin's cells. United States patent US 5304635. 1994 Apr 19. (WB)8. Zhou C, Lu L, Tan S, Jiang S, Chen Y. HIV-1 glycoprotein 41 ectodomain induces activation of the CD74 protein-mediated extracellular signal-regulated kinase/mitogen-activated protein kinase pathway to enhance viral infection. J Biol Chem. 2011;286:44869-77. (Block)9. Klasen C, Ohl K, Sternkopf M, Schachar I, Schmitz C, Heussen N, et al. MIF promotes B cell chemotaxis through the receptors CXCR4 and CD74 and ZAP-70 signaling. J Immunol. 2014;192:5273-84. (Block)10. Aiello A, Delia D, Borrello MG, Biassoni D, Giardini R, Fontanella E, et al. Flow cytometric detection of the mitochondrial BCL-2 protein in normal and neoplastic human lymphoid cells. Cytometry. 1992;13:502-9. (FC)11. Butrym A, Majewski M, Dzietczenia J, Kuliczkowski K, Mazur G. High CD74 expression correlates with ZAP70 expression in B cell chronic lymphocytic leukemia patients. Med Oncol. 2013;30:560. (FC) |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies